Anguilla vs Antigua and Barbuda: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Anguilla
0.2%
in 2024
Antigua and Barbuda
0.2%
in 2024
Anguilla rank
98th
Antigua and Barbuda rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Anguilla
- Antigua and Barbuda
How they compare
Anguilla currently reports 0.2% against 0.2% in Antigua and Barbuda, a difference of 0.0%.
Across all 10 years both countries report, Antigua and Barbuda has been ahead every year.
Anguilla ranks 98th and Antigua and Barbuda ranks 98th of 246 countries.
Head to head by decade
| Decade | Anguilla | Antigua and Barbuda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Anguilla or Antigua and Barbuda?
- Anguilla, at 0.2% against 0.2% in Antigua and Barbuda as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Anguilla and Antigua and Barbuda?
- 0.0%, with Anguilla ahead.
- How many years of comparable data are there for Anguilla and Antigua and Barbuda?
- 10 years are reported by both, from 2015 to 2024.
- How do Anguilla and Antigua and Barbuda rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Anguilla ranks 98th and Antigua and Barbuda ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.